Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma

European Journal of Cancer

Volumn 43, Issue 6, 2007, Pages 1037-1044

  Peet, Andrew C ^a,b   Davies, Nigel P ^a,c   Ridley, Lee ^d   Brundler, Marie Anne ^b   Kombogiorgas, Dimitris ^b   Lateef, Shaheen ^b   Natarajan, Kal ^a,c   Sgouros, Spyros ^b   MacPherson, Lesley ^b   Grundy, Richard G ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Children; Magnetic resonance spectroscopy; Medulloblastoma; Metastases

Indexed keywords

ADOLESCENT; ARTICLE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR VOLUME;

ADOLESCENT; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; HEAD AND NECK NEOPLASMS; HUMANS; INFANT; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MEDULLOBLASTOMA; SPINAL NEOPLASMS; TUMOR BURDEN;

EID: 33947574262     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.01.019     Document Type: Article

References (29)

1. Ellison D.W., Onilude O.E., Lindsey J.C., et al. Beta-catenin status predicts a favourable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23 (2005) 7951-7957
2. Gilbertson R.J., Pearson A.D., Perry R.H., Jaros E., and Kelly P.J. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer 71 (1995) 473-477
3. Grotzer M.A., Janss A.J., Fung K., et al. Trk C expression predicts good clinical outcome in primitive neuroectodermal brain tumours. J Clin Oncol 18 (2000) 1027-1035
4. Pomeroy S.L., Tomayo P., Gaasenbeek M., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415 (2000) 436-442
5. Thompson M.C., Fuller C., Hogg T.L., et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24 (2006) 1924-1931
6. Panigraphy A., Krieger M.D., Gonzalez-Gomez I., et al. Quantitative short echo time 1H MR spectroscopy of untreated paediatric brain tumours: pre-operative diagnosis and characterisation. AJNR 27 (2006) 560-572
7. Preul M.C., Caramanos Z., Collins D.L., et al. Accurate, noninvasive diagnosis of human brain tumours by using proton magnetic resonance spectroscopy. Nat Med 2 (1996) 323-325
8. Astrakas L.G., Zurakowski D., Tzikka A.A., et al. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 10 (2004) 8220-8228
9. Girard N., Wang Z.J., Erbetta A., et al. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumours in children. Neuroradiology 40 (1998) 121-125
10. Li X., Jin H., Lu Y., et al. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 17 (2004) 10-20
11. Vaidya S.J., Payne G.S., Leach M.O., and Pinkerton C.R. Potential role of magnetic resonance spectroscopy in assessment of tumour response in childhood cancer. Eur J Cancer 39 (2003) 728-735
12. Warren K.E., Frank J.A., Black J.L., et al. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumours. J Clin Oncol 18 (2000) 1020-1026
13. Preul M.C., Caramanos Z., Leblanc R., Villemure J.G., and Arnold D. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumours. NMR Biomed 11 (1998) 192-200
14. Catalaa I., Henry R., Dillon W.P., et al. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 19 (2006) 463-475
15. Howe F.A., Barton S.J., Cudlip S.A., et al. Metabolic profiles of human brain tumours using quantitative in vivo proton magnetic resonance spectroscopy. Mag Res Med 49 (2003) 223-232
16. Peet A., Garala P., MacPherson L., Natarajan K., Sgouros S., and Grundy R. Mobile lipids detected by short echo time 1H magnetic resonance spectroscopy correlate with malignancy in childhood brain tumours. Neurooncology 6 (2004) 471
17. 1H MRS). Br J Cancer 88 (2003) 478-485
18. Ronen S.M., Jackson L.E., Beloueche M., and Leach M.O. Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells. Br J Cancer 84 (2001) 691-696
19. Glunde K., Jie C., and Bhujwaller Z.M. Molecular causes of aberrant choline phospholipids metabolism in breast cancer. Cancer Res 64 (2004) 4270-4276
20. Rodriguez-Gonzalez A., de Molina A., Fernandez F., et al. Inhibition of choline kinase as a specific cytotoxic strategy in oncogne-transformed cells. Oncogene 22 (2003) 8803-8812
21. Blankenberg F.G., Katsikis P.D., Storrs R.W., et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 89 (1997) 3778-3786
22. Barba I., Cabanas M.E., and Arus C. The relationship between nuclear magnetic resonance visible lipids, lipid droplets and cell proliferation in cultured C6 cells. Cancer Res 59 (1999) 1861-1868
23. Sgouros S., Goldin H.J., Hockley A.D., Wake M.J.C., and Natarajan K. Intracranial volume change in childhood. J Neurosurgery 91 (1999) 610-616
24. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
25. Frahm J., and Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 27 (1996) 64-69
26. 1H NMR spectroscopy identifies differences in choline metabolism related to the MYCN oncogene in neuroblastoma. Proc Intl Soc Mag Reson Med 13 (2005) 2489
27. 1H MRS of brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro. Magma 8 (1999) 121-128
28. Negendank W., and Sauter R. Intratumoral lipids in proton MRS in vivo in brain tumours: experience of the Siemens cooperative clinical trial. Anticancer Res 16 (1996) 1533-1538
29. Peet A.C., Leach M.O., Pinkerton C.R., Price P., Williams S.R., and Grundy R.G. The development of functional imaging for the diagnosis, management and understanding of childhood brain tumours - an EPSRC workshop. Paediatric Blood Cancer 44 (2005) 103-113